Landlocked developing countries (LLDCs) vs Uganda: Percentage of bloodstream infection due to Escherichia coli resistant
Landlocked developing countries (LLDCs)
74.2%
in 2022
Uganda
81.8%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Uganda rank
2nd
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Landlocked developing countries (LLDCs)
- Uganda
How they compare
Uganda currently reports 81.8% against 74.2% in Landlocked developing countries (LLDCs), a difference of 7.6%.
That makes Uganda's figure about 1.1 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Uganda ahead.
Landlocked developing countries (LLDCs) ranks 3rd and Uganda ranks 2nd of 16 groups.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.4% | 53.1% | 14.7% | Uganda |
| 2020s | 73.7% | 83.4% | 9.7% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Landlocked developing countries (LLDCs) or Uganda?
- Uganda, at 81.8% against 74.2% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Landlocked developing countries (LLDCs) and Uganda?
- 7.6%, with Uganda ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Uganda?
- 5 years are reported by both, from 2017 to 2022.
- How do Landlocked developing countries (LLDCs) and Uganda rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Uganda ranks 2nd of 16 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.